This article is more than 5 years old. Information may no longer be current.

Implanet receives FDA 510(k), CE approval to market spinal implant

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Implanet announced it has received FDA 510(k) clearance and CE marketing approval for its Jazz Frame spinal implant.

According to a company press release, the Jazz Frame is a system of connectors and the final link in the Jazz Band technological platform, which is dedicated to a hybrid surgical technique.

“We continue to strictly adhere to, and execute our business plan,” Ludovic Lastennet, chief executive officer of Implanet, said in the release. “The rapid marketing clearance in Europe and the United States is a real source of satisfaction [and] innovation that maximizes the clinical value of our technology. Optimized for implementation of the ‘frame’ technique, we expect this implant to be rapidly adopted by our partner surgeons, pediatric and adult deformity specialists alike. The marketing release of Jazz Frame in our various markets is scheduled for the first quarter of 2017.”

Reference:

www.implanet.com